About Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Switzerland Gives Green Light to Controversial Prenatal Test for Down’s Syndrome

by Kathy Jones on July 30, 2012 at 7:41 PM
Font : A-A+

 Switzerland Gives Green Light to Controversial Prenatal Test for Down’s Syndrome

A Swiss newspaper has reported that the country's health authorities have given a green light for a controversial prenatal test for Down's syndrome even as human rights activists protest that such a test could lead to more abortions.

Testing will be available in the country from mid-August following a decision by Swissmedic, the national agency for therapeutic products, the Neue Zuercher Zeitung am Sonntag reported.

Advertisement

The test, developed by life sciences company LifeCodexx, involves screening pregnant women's blood samples for the presence of foetal Down's syndrome, which is also known as trisomy 21.

The German-based firm described the procedure, marketed as PrenaTest, as a "risk-free alternative to common invasive examination methods such as amniocentesis".
Advertisement

Demand is high in Switzerland from doctors and expectant mothers, the company said. The test will also be marketed in Germany, Austria and Liechtenstein, according to the German-based firm's website.

The Swiss national health insurer Santesuisse and the Swiss gynaecological society are happy for the cost of the test to be reimbursed as part of standard medical cover if it proves successful, the NZZ report said.

But the international federation of Down's syndrome organisations has objected to such testing at the European Court of Human Rights.

The federation, grouping 30 associations in 16 countries, said in June that the Strasbourg court should "recognise the human condition and protect the right to life of people with Down's syndrome and those handicapped".

Down's syndrome is caused by having an extra copy of chromosome 21 and the risk increases as a woman gets older.

Invasive procedures currently used for prenatal diagnosis -- in the 16th week of pregnancy -- pose a one percent risk of foetal loss. The diagnosis is therefore only made available to high risk women, which fails to catch all cases.

Source: AFP
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
COVID Toes
International Yoga Day 2022 - 'Yoga for Humanity'
Wearable Devices Are Now Transforming Depression, Multiple Sclerosis, and Epilepsy Management.
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Pregnancy and Antenatal Care Varicocele 

Most Popular on Medindia

The Essence of Yoga Accident and Trauma Care Blood Donation - Recipients Drug Side Effects Calculator Pregnancy Confirmation Calculator Find a Hospital Turmeric Powder - Health Benefits, Uses & Side Effects Vent Forte (Theophylline) Iron Intake Calculator A-Z Drug Brands in India

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2022

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use